Market Alert: Alcoa Inc. (NYSE:AA), Twenty-First Century Fox (NASDAQ:FOXA), US Physical Therapy Inc. (NYSE:USPH), Newport (NASDAQ:NEWP), Thermo Fisher Scientific (NYSE:TMO)


Rank Group Ltd. and Alcoa Inc. (NYSE:AA) squabbled on Monday before a Manhattan federal judge over who should foot a $10 million Chilean tax bill levied after Rank’s $2.7 billion purchase of packaging businesses, including the Reynolds Wrap brand, with Rank demanding contractual indemnification and Alcoa countering that Rank caused the liability. On Monday shares of Alcoa Inc. (NYSE:AA) closed at $16.08. Company’s sales growth for last 5 years was 5.30% and EPS growth for next 5 years is recorded as 36.48%.

Both Dish and Twenty-First Century Fox, Inc. (NASDAQ:FOXA) are claiming at least partial victories in their legal tussle over how much control the other one has over broadcasted content. Twenty-First Century Fox, Inc. (NASDAQ:FOXA) in last trading activity advanced 0.73% to close at $34.54. Company weekly performance is -1.14% while its quarterly performance stands at 2.98%. Twenty-First Century Fox, Inc. (NASDAQ:FOXA) is -12.04% away from its 52 week high.

Mcdowell Glenn, COO of US Physical Therapy Inc. (NYSE:USPH), unloaded 19,621 shares at an average price of $39.95 on December 5, 2014. The total amount of the transaction was worth $783,859, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing. On last trading day US Physical Therapy Inc. (NYSE:USPH) advanced 1.18% to close at $40.21. Its volatility for the week is 3.63% while volatility for the month is 3.17%. USPH’s sales growth for past 5 years was 7.10% and its EPS growth for past 5 years was 12.10%. US Physical Therapy Inc. (NYSE:USPH) monthly performance is -2.57%.

Newport Corporation (Nasdaq: NEWP) announced that the company will release results for its fourth quarter and full year ended January 3, 2015, on Monday, February 9, 2015. Newport Corp. (NASDAQ:NEWP) has 1.00% insider ownership while its institutional ownership stands at 86.00%. In last trading activity company’s stock closed at $19.11.

Thermo Fisher Scientific, Inc. (NYSE:TMO) has signed an agreement with Cynvenio Biosystems, a molecular testing company focused on the genomic analysis of tumour biomarkers in the bloodstream, for rights to distribute its LiquidBiopsy platform. On last trading day Thermo Fisher Scientific, Inc. (NYSE:TMO) advanced 0.62% to close at $125.64. Its volatility for the week is 1.75% while volatility for the month is 1.75%. TMO’s sales growth for past 5 years was 4.50% and its EPS growth for past 5 years was 9.30%. Thermo Fisher Scientific, Inc. (NYSE:TMO) monthly performance is -0.81%.


Leave a Reply

Your email address will not be published. Required fields are marked *